EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Alternative endpoints to mortality in cancer screening trials

Sir Harpal Kumar

Molecular Oncology · 2024

DOI: 10.1002/1878-0261.13697 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Oncology, 2024. Verfasst von Sir Harpal Kumar. Beteiligte Einrichtung: BioPharma Business & Europe, GRAIL Bio UK Ltd., London, UK. Hauptthemen laut MEDLINE: Early Detection of Cancer, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The reliance on mortality endpoints in cancer screening trials is not always compatible with the need to accelerate progress in outcomes for patient and public benefit. Evaluation of novel cancer screening technologies, such as multi‐cancer early detection (MCED) tests, could be expedited by using alternative metrics that are measurable earlier than mortality. These include endpoints based on cancer stage at diagnosis, such as reduction in late‐stage cancer incidence, and endpoints following cancer diagnosis, such as eligibility for curative therapy. Innovative trial designs with earlier measures that complement cancer mortality are needed to realise the potential benefits of novel screening technologies such as MCEDs more rapidly.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Early Detection of CancerNeoplasmsHumansClinical Trials as TopicEndpoint Determination

Stichwörter der Autor:innen

alternative endpointscancer screeningearly detection of cancerliquid biopsy

Autor:innen und Institutionen

  • BioPharma Business & Europe, GRAIL Bio UK Ltd., London, UK.

Zitieren

APA

Kumar, S. H. (2024). Alternative endpoints to mortality in cancer screening trials. Molecular Oncology. https://doi.org/10.1002/1878-0261.13697

Vancouver

Kumar SH. Alternative endpoints to mortality in cancer screening trials. Molecular Oncology. 2024. doi:10.1002/1878-0261.13697

BibTeX
@article{Kumar2024,
  author = {Kumar, Sir Harpal},
  title = {Alternative endpoints to mortality in cancer screening trials},
  journal = {Molecular Oncology},
  year = {2024},
  doi = {10.1002/1878-0261.13697}
}
Kostenlos starten →